Thyroid is proud to announce our new impact factor of 4.493, a 17% increase over last year! This achievement upholds the Journal’s status as the leading, peer-reviewed journal in its field. As the Official Journal of the American Thyroid Association (ATA), Thyroid delivers the latest findings on topics ranging from basic science to clinical application, and is the exclusive source for authoritative ATA clinical Guidelines on the management of thyroid disease. We wish to extend our deepest thanks to Editor-in-Chief Peter Kopp for his leadership, as well as to the Editorial Board and authors for their hard work and dedication to the ongoing mission of the Journal.
In recognition, we are pleased to provide complimentary access through July 15th to selected top articles from the Journal:
Management of Recurrent/Persistent Nodal Disease in Patients with Differentiated Thyroid Cancer: A Critical Review of the Risks and Benefits of Surgical Intervention Versus Active Surveillance
Ralph P. Tufano, Gary Clayman, Keith S. Heller, William B. Inabnet, Electron Kebebew, Ashok Shaha, David L. Steward, and R. Michael Tuttle, for the American Thyroid Association Surgical Affairs Committee Writing Task Force
Use of Evidence-Based Guidelines Reduces Radioactive Iodine Treatment in Patients with Low-Risk Differentiated Thyroid Cancer
Wendy Sacks, Ronnie Meiyi Wong, Catherine Bresee, and Glenn D. Braunstein
Non-Thyroidal Illness in the ICU: A Syndrome with Different Faces
Greet Van den Berghe
Thyrotropin Suppression Increases the Risk of Osteoporosis Without Decreasing Recurrence in ATA Low- and Intermediate-Risk Patients with Differentiated Thyroid Carcinoma
Laura Y. Wang, Andrew W. Smith, Frank L. Palmer, R. Michael Tuttle, Azhar Mahrous, Iain J. Nixon, Snehal G. Patel, Ian Ganly, James A. Fagin, and Laura Boucai
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.